Guideline for PET/CT imaging of neuroendocrine neoplasms with <sup>68</sup>Ga-DOTA-conjugated somatostatin receptor targeting peptides and <sup>18</sup>F-DOPA.
MetadataShow full item record
Purpose & methods Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using <sup>68</sup>Ga-DOTA-conjugated peptides, as well as <sup>18</sup>F-DOPA imaging for various neuroendocrine neoplasms.Results & conclusion The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with <sup>68</sup>Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
Version of record
Heterocyclic Compounds, 1-Ring
Image Interpretation, Computer-Assisted
Practice Guidelines as Topic
Positron Emission Tomography Computed Tomography
Translational Molecular Imaging
License start date
European journal of nuclear medicine and molecular imaging, 2017, 44 (9), pp. 1588 - 1601